安進是全球生物科技醫藥領導者 。以價值觀為基礎,深根於科學和創新,為患有嚴重疾病的病患提供治療藥物。安進致力於探索、開發、製造和提供創新治療藥物,開拓生物科技潛能,幫助病患對抗嚴重疾病;並運用先進的人類遺傳學知識,揭開疾病的複雜性,瞭解人體生物學的基礎。
了解安進以不同的節奏運作,加速最新醫學發現的速度,研發創新藥物供病患使用。
The rhythm of life unfolds at an ever-changing pace. Some moments pass in a blur. Others tick by in slow motion.
But no matter what the pace of life, nothing is more valuable than the time we have to experience it—and the chance we have to live each moment to its fullest.
That’s why Amgen operates at a different rhythm, moving quickly toward the future by combatting the world’s toughest diseases.
With roots in the biotech revolution, today Amgen is one of the world’s leading independent biotech companies.
With each decade, we stay on the cutting edge of medical discovery, inventing powerful therapies—and reliably delivering them to patients.
We fight the toughest diseases, such as cancer, heart disease, asthma, and osteoporosis to help millions of people globally.
We live in a new era of human health. And Amgen continues to accelerate the pace of change--operating sustainably and drawing upon our deep knowledge of science to push beyond what’s known today.
We tap into a vast library of human and genetic data to unearth new insights into treating disease.
We are creating new therapies that are more precise and personalized than ever before, advancing medicines that can work in new ways, such as targeting multiple pathways in the body at the same time.
Machine learning and artificial intelligence help us make medicines more quickly and effectively by helping to predict if they’ll be safe and effective.
We’re also removing barriers that limit equitable access to healthcare to make our medicines available to more patients around the world.
At Amgen, our mission is to serve patients because we want these rhythms of life to continue. We want you, and your loved ones, to make every moment count—and to count on having more moments.
安進研發可治療嚴重疾病的藥物,銷售至全球逾 100 個國家及地區,協助數百萬人對抗癌症、腎臟、免疫、骨骼和其他嚴重疾病。我們針對病患未被滿足的醫療需求開發藥物,或針對現有藥物提供其他可行的替代治療。
對人體基本生物機轉的瞭解,是安進研發的一大特點,這份瞭解對於安進開發廣泛深入的潛力新藥,也帶來許多貢獻。安進以「生物學優先」的方法,探索疾病的複雜分子路徑,研究藥物能提供的最佳療效和安全性。人類遺傳學持續進展,成為照亮疾病分子根源的曙光;安進期望能持續改進辨識、確認疾病的治療標的。
全世界數百萬重病病患的治療,仰賴以安全可靠方法生產的生物製劑,包括注射或靜脈注射藥物。安進是生物製藥的全球領導者,在提供高品質藥物擁有優異的記錄。為確保每批生物製劑的品質,安進投入技術、經驗以及盡責不鬆懈的承諾。在安進,嚴格的品質控制和藥物的可靠供應與科學創新同樣重要。
雖然為患有嚴重疾病的人們提供創新藥物是安進為社會做出最大貢獻的方式,但我們知道社會面臨著多重挑戰,而我們正在努力盡自己的一份力量來應對這些挑戰。我們的努力可以歸納為以下四個核心策略: